MSH|^~\&|LAB|DH|||202003111311||ORU^R01|4184629|D|2.3|||AL|NE
PID|1||DH00002215|DH2159|LABWDHTEST^SIX^||19460606|F||||||||||DH000084/19|
OBR|1|40260^LAB|00030367^1003:H00006R^LAB^100320:H6^40260|180.0000^PBSR^Peripheral Blood Smear Request^^^XCA01592-5||202003101700|202003101241|||||||202003111241||||||||||LAB|I||||

MSH|^~\&|LAB|RMH|||202003111311||ORU^R01|4184630|D|2.3|||AL|NE
PID|1||RM00003583|RM3169|LABTEST^RMH^SOFT WARE UP'DATED||19850307|F||||||||||RM000106/19|9875077422
OBR|1|40278^LAB|00030383^1103:CE00001R^LAB^110320:CE1^40278|500.5640^BNP^B type Natriuretic Peptide^^^30934-4||202003111111|202003110800|||||||202003111110||||||||||LAB|F||||
OBX|1|ST|500.5650^BNP R^B Type Natriuretic Peptide^^30934-4^30934-4|1|124^^Y|pg/mL|0-100|H||A^S|F|||202003111311
NTE|1||BNP Interpretive Guidelines:
NTE|2||< 100     pg/mL  Does not support CHF
NTE|3||100 - 250 pg/mL  Borderline zone CHF
NTE|4||250 - 400 pg/mL  Supports CHF
NTE|5||> 400     pg/mL  Strongly supports CHF
NTE|6||Contact designated speciality Pathologist if required.